Elastography as Gouty Arthropathy Outcome (EGO)

Elastography as Gouty Arthropathy Outcome (EGO), a Pilot Study.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02471261

Enrollment

Registered

2015-06-15

Start date

2015-05-31

Completion date

2017-03-31

Last updated

2020-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout

Brief summary

Elastography as Gouty Arthropathy Outcome (EGO), a pilot study.

Detailed description

Pilot study to assess 10 subjects with tophaceous gout on urate lowering therapy or about to begin urate lowering therapy.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Subjects who are at least 18 years of age but younger than or equal to 99 years of age. 2. Subjects with gouty arthritis as determined by the ACR 1977 classification criteria for gouty arthritis. 3. Subjects with one palpable tophus detectable by one of the three clinical parameters described. \-

Exclusion criteria

1. Subjects who are not eligible for urate lowering treatment or show a hypersensitivity to these drugs or class of compounds. 2. Subjects with significant cardiovascular, neuropsychiatric, hematologic, hepatic, renal or endocrine dysfunction who in the opinion of the principal investigator are unfit for participation in a clinical trial. 3. Subjects for which the clinical and laboratory assessment would provide undue discomfort and / or are contraindicated. \-

Design outcomes

Primary

Measure	Time frame	Description
Elastography as Gouty Arthropathy Outcome (EGO), a pilot study	1 year	Observational trial to measure gouty arthritis changes in subject taking urate lowering therapies

Countries

United States

Outcome results